Topic: Stock Price Movements — Technical Analysis
Jul. 10 2015, 5:48 PM ET - by VF member vanmeerten (903 )

7-10.png

Anacor Pharmaceuticals - Chart of the Day --

The Chart of the Day belongs to Anacor Pharmaceuticals (ANAC), I found the pharmaceutical preparations stock by using Barchart to sort today's All Time High list for the stocks with the highest Weighted Alpha then used the Flipchart feature to review the charts, Since the Trend Spotter signaled a buy in 5/12 the stock gained 35.27%



Anacor Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovery, development and commercialization of novel small-molecule therapeutics derived from its boron chemistry platform. Its three lead product candidates include two topically administered dermatologic compounds-AN2690, an antifungal for the treatment of onychomycosis, and AN2728, an anti-inflammatory for the treatment of psoriasis, as well as a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria-GSK2251052. Additionally, the Company also develops topical antifungal product for the treatment of onychomycosis and skin fungal infections, topical anti-inflammatory product for the treatment of psoriasis and atopic dermatitis. Anacor Pharmaceuticals, Inc. is headquartered in Palo Alto, California.

The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report


Barchart technical indicators:
100% Barchart technical buy signals
Trend Spotter buy signal
Above its 20, 50 and 100 day moving averages
9 new highs and up 21.20% in the last month
Relative Strength Index 74.18%
Barchart computes a technical support level at 76.67
Recently traded at 84.61 with a 50 day moving average of 69.12

Fundamental factors:

Market Cap $3.7 billion
Revenue expected to grow 255.20% this year and another 58.20% next year
Earnings estimated to increase 44.20% this year and an additional 80.00% next year
Wall Street analysts issued 3 strong buy, 1 buy and 1 hold recommendation on the stock

The 20-100 Day MACD Oscillator has been a reliable technical trading strategy for this stock and should continue to be used for entry and exit points.

Click To Add Your POITIVE Recommendation!   |  Currently:   56 positive